(2S,5S,8S,11S,14S,17S,20S)-14-((1H-indol-3-yl)methyl)-20-amino-17-(4-hydroxybenzyl)-11-(hydroxymethyl)-8-isobutyl-2,5-dimethyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-2-((13S,16S)-1,8,19-triamino-13-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-6,15,19-trioxo-5,7,9,14-tetraazanonadec-7-en-16-ylcarbamoyl)pyrrolidin-1-yl)-3,6,9,12,15,18-hexaazatricosan-23-oic acid Tris(hydrotrifluoroacetate)

ID: ALA3786583

Chembl Id: CHEMBL3786583

PubChem CID: 127030940

Max Phase: Preclinical

Molecular Formula: C76H104F9N19O23

Molecular Weight: 1480.69

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN/C(N)=N\C(=O)NCCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C70H101N19O17.3C2HF3O2/c1-38(2)32-51(85-66(103)54(37-90)87-65(102)53(35-43-36-78-47-17-9-8-16-45(43)47)86-64(101)52(34-42-20-22-44(91)23-21-42)84-60(97)46(72)24-27-57(93)94)63(100)79-39(3)59(96)80-40(4)68(105)89-31-13-19-55(89)67(104)82-49(25-26-56(73)92)62(99)81-48(18-12-30-76-69(75)88-70(106)77-29-11-10-28-71)61(98)83-50(58(74)95)33-41-14-6-5-7-15-41;3*3-2(4,5)1(6)7/h5-9,14-17,20-23,36,38-40,46,48-55,78,90-91H,10-13,18-19,24-35,37,71-72H2,1-4H3,(H2,73,92)(H2,74,95)(H,79,100)(H,80,96)(H,81,99)(H,82,104)(H,83,98)(H,84,97)(H,85,103)(H,86,101)(H,87,102)(H,93,94)(H4,75,76,77,88,106);3*(H,6,7)/t39-,40-,46-,48-,49-,50-,51-,52-,53-,54-,55-;;;/m0.../s1

Standard InChI Key:  BLNJCQPCLMLZSB-FVXXQQPCSA-N

Associated Targets(Human)

NPFFR2 Tchem Neuropeptide FF receptor 2 (533 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1480.69Molecular Weight (Monoisotopic): 1479.7623AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Keller M, Kuhn KK, Einsiedel J, Hübner H, Biselli S, Mollereau C, Wifling D, Svobodová J, Bernhardt G, Cabrele C, Vanderheyden PM, Gmeiner P, Buschauer A..  (2016)  Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.,  59  (5): [PMID:26824643] [10.1021/acs.jmedchem.5b01495]

Source